PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8680546-0	1996	Duration of anti-cholecystokinin (CCK) action on the rat exocrine pancreas of new CCK receptor antagonist FK480 administered orally.	FR 120480	106-111	cholecystokinin	Rattus norvegicus	34-37	
8680546-0	1996	Duration of anti-cholecystokinin (CCK) action on the rat exocrine pancreas of new CCK receptor antagonist FK480 administered orally.	FR 120480	106-111	cholecystokinin	Rattus norvegicus	82-85	
8680546-1	1996	We assessed the duration of the anti-cholecystokinin (CCK) action of FK480, a new non-peptide CCK-A receptor antagonist developed in Japan, in an in vivo study in rats, comparing it with CR 1505.	FR 120480	69-74	cholecystokinin	Rattus norvegicus	54-57	
8680546-3	1996	FK480 significantly inhibited both CCK-stimulated pancreatic juice volume flow and amylase output 0, 4, 8, and 12 h after oral administration, whereas the inhibitory effect of CR 1505 had completely disappeared by 8 h after oral administration.	FR 120480	0-5	cholecystokinin	Rattus norvegicus	35-38	
8680546-4	1996	It was concluded that orally administered FK480 has a prolonged anti-CCK action.	FR 120480	42-47	cholecystokinin	Rattus norvegicus	69-72